Genenta Science S.p.A.
GNTACIK 0001838716 · Biological Products, (No Diagnostic Substances) · Nasdaq
- Genenta Science S.r.l. (until 2021-05-19)
Revenue (TTM)
—
FY Dec 2025
Net Income (TTM)
−€6.53M
+26.7% YoY
FY Dec 2025
EPS Diluted (TTM)
−€0.33
+32.7% YoY
FY Dec 2025
Gross Margin
—
FY Dec 2025
Operating Margin
—
FY Dec 2025
Net Margin
—
FY Dec 2025
Free Cash Flow (TTM)
−€6.88M
FY Dec 2025
Cash
€5.53M
FY Dec 2025
Total Debt
—
FY Dec 2025
Shares Outstanding
23.43M sh
FY Dec 2025
Revenue & Net Income
EPS (Diluted)
Cash Flow
Revenue Growth (YoY)
No data available for this metric.